Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug;21(4):417-427.
doi: 10.1007/s11897-024-00674-w. Epub 2024 Jun 28.

Precision Phenotyping of Heart Failure in People with HIV: Early Insights and Challenges

Affiliations
Review

Precision Phenotyping of Heart Failure in People with HIV: Early Insights and Challenges

Eli Grunblatt et al. Curr Heart Fail Rep. 2024 Aug.

Abstract

Purpose of review: People with HIV have an elevated risk of developing heart failure even with optimally controlled disease. In this review, we outline the various mechanisms through which HIV infection may directly and indirectly contribute to heart failure pathology and highlight the emerging relationship between HIV, chronic inflammation, and cardiometabolic disease.

Recent findings: HIV infection leads to chronic inflammation, immune dysregulation, and metabolic imbalances even in those with well controlled disease. These dysregulations occur through several diverse mechanisms which may lead to manifestations of different phenotypes of heart failure in people with HIV. While it has long been known that people with HIV are at risk of developing heart failure, recent studies have suggested numerous complex mechanisms involving chronic inflammation, immune dysregulation, and metabolic derangement through which this may be mediated. Further comprehensive studies are needed to elucidate the precise relationship between these mechanisms and the development of different subtypes of heart failure in people with HIV.

Keywords: HFpEF; HFrEF; HIV; Heart Failure; Inflammation; Metabolic Dysregulation.

PubMed Disclaimer

Similar articles

References

    1. Cohen I, Anderson DW, Virmani R, Reen BM, Macher AM, Sennesh J, et al. Congestive cardiomyopathy in association with the acquired immunodeficiency syndrome. N Engl J Med. 1986;315:628–30. https://doi.org/10.1056/NEJM198609043151007 . - DOI - PubMed
    1. Acierno L. Cardiac complications in acquired immunodeficiency syndrome (AIDS): a review. J Am Coll Cardiol. 1989;13(5):1144–54. https://doi.org/10.1016/0735-1097(89)90277-5 . - DOI - PubMed
    1. Sinha A, Feinstein MJ. Immune dysregulation in myocardial fibrosis, steatosis, and heart failure: current insights from HIV and the general population. Curr HIV/AIDS Rep. 2021;18:63–72. https://doi.org/10.10007/s11904-020-00536-9 . - DOI - PubMed
    1. Strategies for Management of Antiretroviral Therapy Study G E-S, Lundgren WM, Neaton JD, Gordin JD, Abrams F. CD4 + count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355(20):2283–96. https://doi.org/10.1056/NEJMoa062360 . - DOI
    1. Go A, Reynolds K, Avula HR, Towner WJ, Hechter RC, Horberg MA et al. Human immunodeficiency virus infection and variation in heart failure risk by age, sex, and ethnicity: the HIV HEART study. Mayo Clin Proc. 2022;97(3):465 – 79. https://doi.org/10.1016/j.mayocp.2021.10.004 .

LinkOut - more resources